Gene · 9536
Papers2,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer. | Int J Mol Sci | 2023 | 36835130 | PubTator, text mining | PubMed |
| Acquisition of Immune Privilege in GBM Tumors: Role of Prostaglandins and Bile Salts. | Int J Mol Sci | 2023 | 36834607 | PubTator, text mining | PubMed |
| Homozygous Missense Variant in the Solute Carrier Organic Anion Transporter 2A1 (SLCO2A1) Gene Underlies Isolated Nail Clubbing. | Genes (Basel) | 2023 | 36833358 | PubTator, text mining | PubMed |
| Helichrysum italicum: From Extraction, Distillation, and Encapsulation Techniques to Beneficial Health Effects. | Foods | 2023 | 36832877 | PubTator, text mining | PubMed |
| Cannabinoids Transmogrify Cancer Metabolic Phenotype via Epigenetic Reprogramming and a Novel CBD Biased G Protein-Coupled Receptor Signaling Platform. | Cancers (Basel) | 2023 | 36831374 | PubTator, text mining | PubMed |
| Cellular and Molecular Control of Lipid Metabolism in Idiopathic Pulmonary Fibrosis: Clinical Application of the Lysophosphatidic Acid Pathway. | Cells | 2023 | 36831215 | PubTator, text mining | PubMed |
| The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells. | Biomedicines | 2023 | 36830980 | PubTator, text mining | PubMed |
| Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer. | JCI Insight | 2023 | 36821396 | PubTator, text mining | PubMed |
| Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development. | Front Physiol | 2023 | 36818443 | PubTator, text mining | PubMed |
| Inflammatory response: The target for treating hyperpigmentation during the repair of a burn wound. | Front Immunol | 2023 | 36817442 | PubTator, text mining | PubMed |
| The role of TNF-α in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment. | Front Immunol | 2023 | 36814921 | PubTator, text mining | PubMed |
| Hydroxylation markedly alters how the polychlorinated biphenyl (PCB) congener, PCB52, affects gene expression in human preadipocytes. | Toxicol In Vitro | 2023 | 36804509 | PubTator, text mining | PubMed |
| Virtual screening, molecular simulations and bioassays: Discovering novel microsomal prostaglandin E Synthase-1 (mPGES-1) inhibitors. | Comput Biol Med | 2023 | 36780799 | PubTator, text mining | PubMed |
| Inhibition of specific signaling pathways rather than epigenetic silencing of effector genes is the leading mechanism of innate tolerance. | Front Immunol | 2023 | 36776861 | PubTator, text mining | PubMed |
| Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells. | Front Oncol | 2023 | 36776289 | PubTator, text mining | PubMed |
| Glutathione-Related Enzymes and Proteins: A Review. | Molecules | 2023 | 36771108 | PubTator, text mining | PubMed |
| Microsomal Prostaglandin E Synthase-1 and -2: Emerging Targets in Non-Alcoholic Fatty Liver Disease. | Int J Mol Sci | 2023 | 36769370 | PubTator, text mining | PubMed |
| Molecular and Biologic Effects of Platelet-Rich Plasma (PRP) in Ligament and Tendon Healing and Regeneration: A Systematic Review. | Int J Mol Sci | 2023 | 36769065 | PubTator, text mining | PubMed |
| Mechanobiology of the Human Intervertebral Disc: Systematic Review of the Literature and Future Perspectives. | Int J Mol Sci | 2023 | 36769050 | PubTator, text mining | PubMed |
Synthesis and Significance of Arachidonic Acid, a Substrate for Cyclooxygenases, Lipoxygenases, and Cytochrome P450 Pathways in the Tumorigenesis of Glioblastoma Multiforme, Including a Pan-Cancer Comparative Analysis. | Cancers (Basel) | 2023 | 36765904 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9536/papers?page=16